Aida Oncology is part of the latest cohort of companies accepted on the Bioinnovation Institute’s Venture Lab programme.

The year-long programme will enable Aida to build the company and start to develop a product that will help to ensure that cancer patients are given the right drugs.

Details here.

More details on the BaseLaunch website.

This paper from Melatonin Research discusses novel techniques for biological synthesis of melatonin

RhoVac AB has completed the acquisition of the Danish privately owned oncology company Chosa ApS (“Chosa”). As a result, a new board of directors of Chosa has taken office, and Peter Buhl Jensen replaces Lars Hedbys as CEO. More details on the Chosa website.

Should you raise venture capital for your startup? If so, how much?

Get some great advice in this article on Medium.

In this fascinating interview with Labiotech Refresh Andrea Wallnöfer explains why good clinical trial design can be key to a biotech’s success.

Read this interview with Double Founder Neil Goldsmith to learn more about how to detect startup-suitable talent and his current involvement with BaseLaunch.